These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 7287218

  • 1. Kinetics of inflammation and sarcoma cell development in primary Moloney sarcoma-virus-induced tumors.
    Becker S, Haskill S.
    Int J Cancer; 1981 Feb 15; 27(2):229-34. PubMed ID: 7287218
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The murine sarcoma virus (MSV).
    Harvey JJ, East J.
    Int Rev Exp Pathol; 1971 Feb 15; 10():265-360. PubMed ID: 4333859
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts.
    Kiessling R, Bataillon G, Lamon EW, Klein E.
    Int J Cancer; 1974 Nov 15; 14(5):642-8. PubMed ID: 4459279
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modification of the response of autochthonous Moloney sarcoma virus-induced tumors to poly I:C by DEAE-dx 1 .
    Kende M, Glynn JP.
    Chemotherapy; 1971 Nov 15; 16(5):281-93. PubMed ID: 5146951
    [No Abstract] [Full Text] [Related]

  • 10. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L, Colombatti A, Collavo D, Sendo F, Aoki T, Fischinger PJ.
    J Exp Med; 1974 Nov 01; 140(5):1162-79. PubMed ID: 4608945
    [Abstract] [Full Text] [Related]

  • 11. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA, Chirigos MA, Chan SP.
    Cancer Res; 1969 May 01; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of indomethacin on Moloney sarcoma virus-induced tumors.
    Humes JL, Cupo JJ, Strausser HR.
    Prostaglandins; 1974 Jun 25; 6(6):463-73. PubMed ID: 4366406
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The cellular events associated with regression and progression of murine (Moloney) sarcomas.
    Russell SW, Cochrane CG.
    Int J Cancer; 1974 Jan 15; 13(1):54-63. PubMed ID: 4856384
    [No Abstract] [Full Text] [Related]

  • 16. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H, Chused TM, Herberman RB, Holden HT, Lavrin DH.
    J Exp Med; 1974 Jun 01; 139(6):1473-87. PubMed ID: 4598016
    [Abstract] [Full Text] [Related]

  • 17. Resistance to Moloney murine sarcoma virus-induced tumorigenesis in NK-deficient beige mice.
    Truesdale AT, Johnson DA, Bedigian HG, Outzen HC, Carlson GA.
    Cell Immunol; 1982 Nov 15; 74(1):120-5. PubMed ID: 7159936
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of tumor growth and survival of aged mice inoculated with Moloney tumor transplants and treated with endotoxin.
    Strausser HR, Bober LA.
    Cancer Res; 1972 Oct 15; 32(10):2156-9. PubMed ID: 4562825
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.